Arrowhead Director Sells Shares Following Financial Reporting; Stock Trades Near 52-Week High
A director at Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), recently sold a portion of the company's common stock. This activity occurred alongside positive financial disclosures for the second quarter of fiscal year 2026, where both revenue and earnings surpassed analyst forecasts. Despite strong operational performance reported in Q2 2026, the c…